The sequence and analysis of the gibbon genome was published today in the journal Nature and led by scientists at Oregon Health & Science University, the Baylor College of Medicine Human Genome Sequencing Center and the Washington University School of Medicine’s Genome Institute.

The development and clinical implementation of the Whole Exome Sequencing test derives from a joint effort by Baylor's Human Genome Sequencing Center and Baylor Miraca Genetics Laboratories to establish a clinical laboratory dedicated to state-of-the-art next generation sequencing.

BCM-HGSC in the News

An international consortium of researchers led by Baylor College of Medicine has identified for the first time a gene associated with familial glioma (brain tumors that appear in two or more members of the same family) providing new support that certain people may be genetically predisposed to the disease.

Dr. Matthew Bainbridge, first author on the report, combed through the sequencing data and identified mutations in a gene called POT1, which was present in two of the families.

An international collaboration of scientists including Dr. Stephen Richards at the Baylor College of Medicine Human Genome Sequencing Center has completed the first genome sequence of a myriapod, Strigamia maritima—a member of a group venomous centipedes that care for their eggs—and uncovered new clues about their biological evolution and unique absence of vision and circadian rhythm.

“The novelty of this study involves associating mutation patterns with different ethnic groups,” said Dr. David Wheeler, professor in the Baylor College of Medicine Human Genome Sequencing Center and a corresponding author of the report.

“The routine application of new genome methods in the clinic is not only benefitting patients but changing the way we think about research,” said Dr. Richard Gibbs, director of the Baylor College of Medicine Human Genome Sequencing Center and an author of the report.

Quick Links

About Us

The BCM-HGSC, founded in 1996, is a world leader in genomics.

The fundamental interests of the BCM-HGSC are in advancing biology and genetics by improved genome technologies.

One of three large-scale sequencing centers funded by the National Institutes of Health, the BCM-HGSC's location at the heart of the Texas Medical Center provides a unique opportunity to apply the cutting edge of genome technologies in science and medicine.